Lipid Reagents

(4-ACETYLAMINO-BENZENESULFONYLAMINO)-CYCLOHEXA-1 4-DIENYL-ACETIC ACID-

(4-Bromo-1,2-phenylene)dimethanol.

(4-Bromo-1,2-phenylene)dimethanol.

(4R,5R)-2,2-Dimethyl-α,α,α',α'-tetra(1-naphthyl)-1,3-dioxolane-4,5-dimethanol.

(6-Methyl-4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)acetic acid.

(&plusmn)12-HpETE is one of the six monohydroperoxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid (Item No. 90010) and consists of an equal mixture of the R and S isomers.

(&plusmn)9-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The individual R and S isomers of racemic HETEs have been separated and identified using chiral phase HPLC.

(&plusmn)9-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The individual R and S isomers of racemic HETEs have been separated and identified using chiral phase HPLC.

(±)-Vasicine is the racemate of Vasicine. Vasicine (Peganine) significantly inhibits H + -K + -ATPase activity in vitro with an IC 50 of 73.47 μg/mL. Anti-ulcer activity. Vasicine shows significant anti-secretory, antioxidant

(±)-Vasicine is the racemate of Vasicine. Vasicine (Peganine) significantly inhibits H + -K + -ATPase activity in vitro with an IC 50 of 73.47 μg/mL. Anti-ulcer activity. Vasicine shows significant anti-secretory, antioxidant

(E)-1-(4-bromophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one.

(E)-1-(4-bromophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one.